Camelina Oil Snacks Show Promise for Reducing Inflammation in Older Adults

This completed clinical trial examined whether camelina sativa oil, delivered through enriched snacks, could reduce inflammation in older adults. The study targeted inflammation, malnutrition, and hyperglycemia as key health concerns in aging populations.

Researchers conducted a randomized, double-blind, placebo-controlled trial involving 91 apparently healthy adults aged 65 and older. Participants were randomly assigned to consume either snacks enriched with camelina sativa oil or identical placebo snacks for 12 weeks. The study ran from January 2019 to March 2021.

Camelina sativa oil contains high levels of omega-3 fatty acids, particularly alpha-linolenic acid, which has demonstrated anti-inflammatory properties in previous research. The intervention was designed as a practical, food-based approach that older adults could easily incorporate into their daily routines.

While specific results weren't detailed in the available summary, the trial measured inflammatory markers before and after the 12-week intervention period. The study's completion suggests researchers successfully gathered data on the oil's potential anti-inflammatory effects in this population.

This research addresses a critical aspect of healthy aging, as chronic low-grade inflammation contributes to numerous age-related diseases. If effective, camelina oil supplementation through food products could offer a simple, accessible strategy for supporting healthy aging and potentially reducing inflammation-related health risks in older populations.